Immuto Scientific is on a mission to drug the 'undruggable'. We enable the discovery of first-in-class and best-in-class therapeutics against challenging targets with a proprietary, disruptive drug discovery platform. Immuto’s breakthrough technology analyzes protein structure, dynamics, and interactions with an unprecedented degree of speed, resolution, and accuracy. Our platform is universally compatible and works on complex membrane protein drug targets, such as GPCRs and ion channels that are not compatible with current analytical techniques or for which no structural information exists.
Speaker
